Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marc Steven Sabatine, M.D.

Co-Author

This page shows the publications co-authored by Marc Sabatine and Ik-Kyung Jang.
Connection Strength

1.031
  1. A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris. Am J Cardiol. 2001 Sep 01; 88(5):488-92.
    View in: PubMed
    Score: 0.239
  2. Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase. J Thromb Thrombolysis. 2000 Oct; 10(2):189-96.
    View in: PubMed
    Score: 0.224
  3. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med. 2000 Aug 15; 109(3):224-37.
    View in: PubMed
    Score: 0.222
  4. Antithrombotic therapy in acute coronary syndromes. Acta Cardiol. 1999 Feb; 54(1):3-29.
    View in: PubMed
    Score: 0.200
  5. Elevation in serum troponin I predicts the benefit of tirofiban. J Thromb Thrombolysis. 2001 May; 11(3):211-5.
    View in: PubMed
    Score: 0.058
  6. Primary versus rescue percutaneous coronary intervention in patients with acute myocardial infarction. Acta Cardiol. 2000 Jun; 55(3):187-92.
    View in: PubMed
    Score: 0.055
  7. Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy. Am J Cardiol. 2003 Feb 15; 91(4):457-61.
    View in: PubMed
    Score: 0.017
  8. Comparison of two different methods of quantitative coronary angiography in patients with acute coronary syndromes. Catheter Cardiovasc Interv. 2002 Apr; 55(4):442-9.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.